Journal of Alzheimers Disease

Article	Citations
Validation of Spatial Orientation Screening questionnaire for use in memory clinic patients	106
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	104
Amyloid-β positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes	97
A longitudinal cohort study demonstrating the beneficial effect of moderate consumption of green tea and coffee on the prevention of dementia: The JPHC Saku Mental Health Study	91
The partner paradox: How can we better understand shared cognitive decline in couples?	90
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	88
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	88
Social isolation and social cognition: A cross-sectional analysis	86
Global amyloid burden enhances network efficiency of tau propagation in the brain	86
Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database	75
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	73
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	71
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	66
The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC)	60
Association of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: New Entity or Coincidence? A Case Series	59
Research Attitudes Questionnaire scores and retention in a recruitment registry	59
Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management	58
Effects of the Participation and Involvement of Medical Professionals in Dementia Cafés on the Attendance of People with Dementia Living at Home and Their Family Caregivers	57
Capgras Syndrome as the Core Manifestation of Early-Onset Alzheimer’s Disease	55
Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer’s Disease Mice	55
Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer’s Disease, Vascular Dementia, Psychobehavioral, and Functional Complications	53
Hippocampal Glutathione Depletion and pH Increment in Alzheimer’s Disease: An in vivo MRS Study	53
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	52
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	51
Acupuncture as a Complementary Therapy for Alzheimer’s Disease	51

Non-Pharmacological Exercise Randomized Controlled Trials in Alzheimer’s Disease	50
Did Reagan Decline?	49
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	49
Oxidative Stress in Alzheimer’s Disease: The Shortcomings of Antioxidant Therapies	47
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	47
Hormone Replacement Therapy and Alzheimer’s Disease: Current State of Knowledge and Implications for Clinical Use	46
Impact of Sarcopenia on Decline in Quality of Life in Older People with Mild Cognitive Impairment	45
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer’s Disease Spectrum	44
A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study	44
Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds	43
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	43
DAPI (4’,6-diamidino-2-phenylindole) Stains Compact Amyloid Plaques	42
Diagnostic Accuracy of the Swedish Version of the Rowland Universal Dementia Assessment Scale (RUDAS-S) for Multicultural Cognitive Screening in Swedish Memory Clinics	42
The Cognition and Flow Study (CogFlowS): A Mixed Method Evaluation of a Randomized Feasibility Trial of Cognitive Training in Dementia	42
Hyperorality in Frontotemporal Dementia: Cognitive and Psychiatric Symptom Profiles in Early-Stage Disease	41
Association Between Grip Strength and Cognitive Function in US Older Adults of NHANES 2011–2014	40
Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer’s Disease Rat Model	40
Identification of Early Onset Dementia in Population-Based Health Administrative Data: A Validation Study Using Primary Care Electronic Medical Records	40
Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition	40
Making the Case for the Accelerated Withdrawal of Aducanumab	39
Quality of Life in Advanced Dementia with Late Onset, Young Onset, and Very Young Onset	38
Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease	38
A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials	38
Photobiomodulation Enhances Memory Processing in Older Adults with Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy Study	38
Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis1	37
Erratum Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in Plasma	37
Polypharmacy and Cognition Function Among Rural Adults	37
Expression and Localization of AβPP in SH-SY5Y Cells Depends on Differentiation State	36
Interaction of Alzheimer’s Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study	36
Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer’s Disease and Cognitively He	36
Current and Future Directions for Targeting Lipoxin A4 in Alzheimer’s Disease	35
Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction	35
The Free and Cued Selective Reminding Test Predicts Braak Stage	35
Age-Related Tau Burden and Cognitive Deficits Are Attenuated in KLOTHO KL-VS Heterozygotes	35
Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer’s Disease and Neurodegeneration	35
Identifying Preclinical Alzheimer’s Disease Using Everyday Driving Behavior: Proof of Concept	34
Poorer Theory of Mind in Amnestic Mild Cognitive Impairment Is Associated with Decreased Functional Connectivity in the Default Mode Network	34
Reliability of Telephone and Videoconference Methods of Cognitive Assessment in Older Adults with and without Dementia	34
Fluid Biomarkers in Clinical Trials for Alzheimer’s Disease: Current and Future Application	34
The Relationship Between Cognitive Performance Using Tests Assessing a Range of Cognitive Domains and Future Dementia Diagnosis in a British Cohort: A Ten-Year Prospective Study	33
Applications of Nanoparticles in Alzheimer’s Disease	33
Sex Differences in Locus Coeruleus: A Heuristic Approach That May Explain the Increased Risk of Alzheimer’s Disease in Females	33
Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer’s Disease	33
Montreal Cognitive Assessment: Normative Data for Cognitively Healthy Swedish 80- to 94-Year-Olds	32
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease	32
Cerebral Microbleeds Are Associated with Impairments in Executive Function and Processing Speed	32
Normative References for Graphomotor and Latency Digital Clock Drawing Metrics for Adults Age 55 and Older: Operationalizing the Production of a Normal Appearing Clock	32
Prognosis and Diagnostic Biomarkers of Mild Traumatic Brain Injury: Current Status and Future Prospects	31
Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care	31
Relationship of Neighborhood Greenness to Alzheimer’s Disease and Non-Alzheimer’s Dementia Among 249,405 U.S. Medicare Beneficiaries	31

Reduced Vision-Related Quality of Life in Dementia: A Preliminary Report	30
Dementia Risk Score for a Population in Southern Europe Calculated Using Competing Risk Models	30
Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden	30
Rethinking Dementia Risk Prediction: A Critical Evaluation of a Multimodal Machine Learning Predictive Model	29
Living Up to the Promise of Preventing Dementia	29
Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer’s Disease from Controls and Predict Progression from Mild Cognitive Impairment	29
Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer’s Disease	29
A Stacking Framework for Multi-Classification of Alzheimer’s Disease Using Neuroimaging and Clinical Features	29
Quantification of COX-2 Level in Alzheimer’s Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target	29
Up Close and Personal with Adult-Onset Leukoencephalopathy	29
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	29
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging	29
Biting the Bullet: Firearm Ownership in Persons with Dementia. A Registry-Based Observational Study	28
The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging	28
Stability of Montreal Cognitive Assessment in Individuals with Mild Cognitive Impairment: Potential Influence of Practice Effect	27
Chronic Stress Induces Hippocampal Mitochondrial Damage in APPPS1 Model Mice and Wildtype Littermates	27
Partnering a Compensatory Application with Activity-Aware Prompting to Improve Use in Individuals with Amnestic Mild Cognitive Impairment: A Randomized Controlled Pilot Clinical Trial	27
Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics	27
An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain	27
Harnessing Passive Pulsatile Shear Stress for Alzheimer’s Disease Prevention and Intervention	27
Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer’s Disease	26
Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN Trial	26
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated	26
Crosstalk Between Gut Microflora and Vitamin D Receptor SNPs Are Associated with the Risk of Amnestic Mild Cognitive Impairment in a Chinese Elderly Population	26
Contactin 5 and Apolipoproteins Interplay in Alzheimer’s Disease	26
Evolution of Clinical-Pathological Correlations in Early-Onset Alzheimer’s Disease Over a 25-Year Period in an Academic Brain Bank	26
Assessment of Cognitive Symptoms in Brain Bank-Registered Control Subjects: Feasibility and Utility of a Telephone-Based Screening	26
Decline in Cognition from Mid-Life Improves Specificity of Mini-Mental State Examination: Diagnostic Test Accuracy in Caerphilly Prospective Study (CaPs)	25
Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer’s Disease Continuum: A Retrospective Observational Study	25
Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study	25
Diagnostic Accuracy of the Swedish Version of the Multicultural Cognitive Examination for Cognitive Assessment in Swedish Memory Clinics	25
Subtle Thyroid Dysfunction Is Not Associated with Cognitive Decline: Results from the ELSA-Brasil	24
Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer’s Disease: Implications for Treatment	24
Language and Meaning: Asymptomatic Alzheimer’s Disease in the Clinic and Society	24
Impact of the Pandemic Time on the Mental Health of People with Dementia and Their Family Caregivers in Brazil and Chile: One-Year Follow-Up	24
Impact of Long-Term Exposure to Air Pollution on Cognitive Decline in Older Adults Without Dementia	24
Documentation of Dementia as a Cause of Death Among Mexican-American Decedents Diagnosed with Dementia	24
Associations Between Neuroinflammation-Related Conditions and Alzheimer’s Disease: A Study of US Insurance Claims Data	24
Chronic Alcohol Exposure Alters Gene Expression and Neurodegeneration Pathways in the Brain of Adult Mice	24
Alzheimer’s Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer’s Disease	24
DEF8 and Autophagy-Associated Genes Are Altered in Mild Cognitive Impairment, Probable Alzheimer’s Disease Patients, and a Transgenic Model of the Disease	24
A Retrospective Study on Clinical Assessment of Cognitive Impairment in a Swedish Cohort: Is There Inequality Between Natives and Foreign-Born?	24
Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?	24
A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks	24
The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer’s Disease: A Longitudinal Study	24
Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer’s Disease in a Naturalistic Clinical Setting	24
De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer’s Disease Associated with Spasticity: A Case Report	23
Safety and Usefulness of Lumbar Puncture for the Diagnosis and Management of Young-Onset Cognitive Disorders	23
Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments	23
The Associations of Plasma/Serum Carotenoids with Alzheimer’s Disease: A Systematic Review and Meta-Analysis	23
Alzheimer’s Disease in Lebanon: Exploring Genetic and Environmental Risk Factors—A Comprehensive Review	23
Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer’s Disease	23
Quantified Brain Magnetic Resonance Imaging Volumes Differentiate Behavioral Variant Frontotemporal Dementia from Early-Onset Alzheimer’s Disease	23
Gut Microbiota and Alzheimer’s Disease: Pathophysiology and Therapeutic Perspectives	23
Is Shadowing Behavior Caused by Body Representation Disorders and Apraxia?	23
Sex and Gender Differences in Environmental Influences on Dementia Incidence in Germany, 2014–2019: An Observational Cohort Study Based on Health Claims Data	23
Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer’s Disease in Humans	23
Relevance of Complaint Severity in Predicting the Progression of Subjective Cognitive Decline and Mild Cognitive Impairment: A Machine Learning Approach	23
Phosphorylation and Dephosphorylation of Tau Protein by the Catalytic Subunit of PKA, as Probed by Electrophoretic Mobility Retard	23
A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer’s Disease	22
Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort	22
A Cross-National Study of Dementia Stigma Among the General Public in Israel and Australia	22
Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk	22
Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer’s Disease	22
Implication of Small Vessel Disease MRI Markers in Alzheimer’s Disease and Lewy Body Disease1	22
Sex Differences in the Association Between LDL/HDL with Cognitive Decline in Older Adults: National Health and Nutrition Examination Survey	22
Instruments to Assess Social Functioning in Individuals with Dementia: A Systematic Review	22
Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk	22
The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer’s Disease: Evidence from Optical Coherence Tomography Angiography	22
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	22
The Oxytocin Puzzle: Unlocking Alzheimer’s Disease	22
Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring$	22
Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer’s Disease Pathology in Later Life	22
Identification of Blood-Based Glycolysis Gene Associated with Alzheimer’s Disease by Integrated Bioinformatics Analysis	22
Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer’s Disease	22
A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer’s Disease via ITGA5	22
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes	22
Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer’s Disease Dementia	22
Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals	22
Metabolomic Alterations in the Blood and Brain in Association with Alzheimer’s Disease: Evidence from in vivo to Clinical Studies	21

High Exhaustion in Geriatric Healthcare Professionals During the COVID-19 Second Lockdown	21
Neuroprotective Effects of the FGF21 Analogue LY2405319	21
A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan	21
Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer’s Disease	21
Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer’s Disease: Cross-Sectional A4 Study	21
A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease	21
Dihydroartemisinin Induces O-GlcNAcylation and Improves Cognitive Function in a Mouse Model of Tauopathy	21
Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study	21
An Introduction to Ultrasensitive Assays for Plasma Tau Detection	21
Personalized Repetitive Transcranial Magnetic Stimulation for Primary Progressive Aphasia	21
Retinal Amyloid Imaging for Screening Alzheimer’s Disease	21
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease	21
Incident Dementia After Spontaneous Intracerebral Hemorrhage	21
The Impact of Built and Social Environmental Characteristics on Diagnosed and Estimated Future Risk of Dementia	21
Aging-Related Protein Alterations in the Brain	20
Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid Deposition	20
The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study	20
White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults	20
Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice	20
Shear-Induced Amyloid Aggregation in the Brain: V. Are Alzheimer’s and Other Amyloid Diseases Initiated in the Lower Brain and Brainstem by Cerebrospinal Fluid Flow Stresses?	20
Impact of COVID-19 on ‘Living Well’ with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort	20
Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Pathology in Cognitively Intact Older Adults: The CABLE Study	20
Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study	20
Discrepancy Between the Degree of Cognitive Impairment and Brain Imaging Abnormalities in Alzheimer’s Disease Patients Is Associated with Cognitive Reserve	20
Simple Quantitative Indices for the Differentiation of Advanced-Stage Alzheimer’s Disease and Other Limbic Tauopathies	20
Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer’s Disease in a Mouse Model	20
Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases	20
Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study	20
Attentional Control in Subjective Cognitive Decline	20
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment	20
Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer’s Disease or Dementia with Lewy Bodies	20
Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank	20
FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer’s Disease	20
Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer’s Disease	20
Differences in Dementia Care Between Swedish-Born and Foreign-Born from Countries with Different Country Level Socioeconomic Position: A Nationwide Register-Based Study	20
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports	19
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1	19
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	19
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study	19
Peptidylarginine Deiminase and Alzheimer’s Disease	19
SHMAD: A Smart Health Care System to Monitor Alzheimer’s Disease Patients	19
Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility	19
Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011–2014)	19
A Qualitative Study on the Experiences of Therapists Delivering the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) Intervention During the COVID-19 Pandemic	19
Sex Differences in Resilience and Resistance to Brain Pathology and Dysfunction Moderated by Cerebrovascular Response to Exercise and Genetic Risk for Alzheimer’s Disease	19
Topographical Overlapping of the Amyloid-β and Tau Pathologies in the Default Mode Network Predicts Alzheimer’s Disease with Higher Specificity	19
Body Mass Index Decrease Has a Distinct Association with Alzheimer’s Disease Pathophysiology in APOE ɛ4 Carriers and Non-Carriers	19
Lessons from Detecting Cognitive Impairment Including Dementia (DetectCID) in Primary Care	19
Hypertension, Cognitive Decline, and Mild Cognitive Impairment Among Diverse Hispanics/Latinos: Study of Latinos-Investigation of Neurocognitive Aging Results (SOL-INCA)	19
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia	19
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols	19
Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer’s Disease	19
Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects	18
Effects of the Multicomponent Cognitive Training Program BrainProtect in Cognitively Healthy Adults: A Randomized Controlled Trial	18
Improved Alzheimer’s Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study	18
Sex-Specific Early Retinal Dysfunction in Mutant TDP-43 Transgenic Mice	18
Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial	18
How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort	18
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study	18
Hypothalamic Functional Connectivity and Apathy in People with Alzheimer’s Disease and Cognitively Normal Healthy Controls	18
Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer’s Disease-Related Risk	18
Erratum to: Shifting the Paradigm of Nursing Home Care for People with Dementia: The Italian Experience of Il Paese Ritrovato and the Impact of SARS-CoV-2	18
Aberrant Cortical Activity in 5xFAD Mice in Response to Social and Non-Social Olfactory Stimuli	18
Erratum to: The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer’s Disease Mouse Model (PS1V97L)	18
Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer’s Disease, Parkinson’s Disease, and Multiple Sclerosis	18
Metabolic and Vascular Risk Factor Variability Over 25 Years Relates to Midlife Brain Volume and Cognition	18
Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype	18
Effects of Mindful Awareness Practice (MAP) on Subclinical Depressive and Anxiety Symptoms and General Cognitive Function in Older Adults with Mild Cognitive Impairment: A 5-Year Follow-Up of the MAP-	18
Synaptic Proteins as Fluid Biomarkers in Alzheimer’s Disease: A Systematic Review and Meta-Analysis	18
Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology	18
Correlation of Blood Metal Concentrations with Cognitive Scores and Neuroimaging Findings in Patients with Total Joint Arthroplasty	18
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES	18
High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer’s Disease Using [11C]AZD2184	18
Tibolone Improves Memory and Decreases the Content of Amyloid-β Peptides and Tau Protein in the Hippocampus of a Murine Model of Alzheimer’s Disease	18
Attitudes and Considerations for Multidomain Lifestyle Approaches to Dementia Prevention: A Qualitative Study	17
Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer’s Disease	17
Automated Video Analysis of Audio-Visual Approaches to Predict and Detect Mild Cognitive Impairment and Dementia in Older Adults	17
Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers	17
Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints	17
Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume	17
Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts	17
PRESENILIN 1 Mutations Causing Early-Onset Familial Alzheimer’s Disease or Familial Acne Inversa Differ in Their Effects on Genes Facilitating Energy Metabolism and Signal Transduction	17
Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer’s Disease	17
The Heritability of Subjective Cognitive Complaints in Older Australian Twins	17
Post-Translational Chemical Modification of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal	17
Evaluation of the Quality and Readability of Online Information about Alzheimer’s Disease in China	17
Associations Between Neighborhood Park Access and Longitudinal Change in Cognition in Older Adults: The Multi-Ethnic Study of Atherosclerosis	17
Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer’s Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks	17
Alzheimer’s Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-β Pathology	17
Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy	17
Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial	17
Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer’s Disease: A Literature Review from a Machine Learning Perspective	17
Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer’s Disease	17
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease	17
Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States	17